Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1986 Jun 28;292(6537):1701-2.
doi: 10.1136/bmj.292.6537.1701.

Effect of somatostatin on renal function

Clinical Trial

Effect of somatostatin on renal function

J P Vora et al. Br Med J (Clin Res Ed). .

Abstract

Somatostatin has profound effects on both splanchnic and portal vascular beds. The effects of intravenous somatostatin (100 micrograms/h) on urinary volume, effective renal plasma flow, and glomerular filtration rate were compared with the effects of a control infusion of physiological saline in six normal subjects. Renal plasma flow and glomerular filtration rate were measured by primed constant isotope infusions of iodine-125 iodohippurate and chromium-51 edetic acid. Urinary volume, renal plasma flow, and glomerular filtration rate were measured during 20 minute clearance periods. During the control infusion urinary volume, renal plasma flow, and glomerular filtration rate remained essentially unchanged at 254 (SEM 3) ml/20 min, 568 (5) ml/min/1.73 m2, and 110 (2) ml/min/1.73 m2 respectively. From similar basal values the infusion of somatostatin led to a rapid decrease in all three variables. After 120 minutes of infusion of somatostatin urinary volume, renal plasma flow, and glomerular filtration rate were reduced to 148 (17) ml/20 min (p less than 0.01), 422 (7) ml/min/1.73 m2 (p less than 0.001), and 93 (3) ml/min/1.73 m2 (p less than 0.05) respectively. This effect on renal function should be borne in mind whenever somatostatin is used.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Clin Lab Invest. 1971 Sep;28(1):91-100 - PubMed
    1. Diabetologia. 1972 Aug;8(4):260-6 - PubMed
    1. Science. 1973 Jan 5;179(4068):77-9 - PubMed
    1. J Clin Invest. 1974 Jan;53(1):190-7 - PubMed
    1. Lancet. 1975 Apr 19;1(7912):886-7 - PubMed

Publication types

LinkOut - more resources